Tag: big pharma

Turns Out ‘Trust the Science’ Came With Receipts

Tulsi Gabbard’s last day as the director of national intelligence is upon us, after she resigned because of a major illness in the family. In her resignation note to the president, she cited her husband Abraham Williams’ recent diagnosis with sacral chordoma — an extremely rare tumor that develops in the sacrum at the base of the spine. In her resignation, she wrote that “He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle.”

That said, there is good news there. The surgery to remove bone and surrounding tissue lasted almost seven hours and was described as successful. Gabbard shared that he had a rough night following that surgery and was in a lot of pain, but was finally home resting, adding “Now recovery begins.”

Gabbard also expressed gratitude for the public support: “We’re so grateful for the outpouring of prayers and kind messages from all of you. Our hearts are full.”

As wonderful as that news is, and as cheered as I am about it, alas! That’s where the feel-good part of this piece ends.

And here are the documents she declassified and released:

COVID-19 Release Index
COVID-19 Release Part 1
COVID-19 Release Part 2
COVID-19 Release Part 3
COVID-19 Release Part 4 

The ODNI press release accompanying the release states that Anthony Fauci, as head of NIAID, 

provided millions in U.S. taxpayer dollars to fund gain-of-function research on bat coronaviruses at the Wuhan Institute of Virology — work the release describes as “widely viewed” as the source of an unintentional lab leak.

I spent some time last night — several hours in fact — going over these documents that I’ve linked above. They lay out the flat-out accusations of Fauci of teaming up with his fellow travelers in the Intelligence Community to kill the lab-leak hypothesis and bury his own fingerprints on the research funding.

And apparently that wasn’t enough — these documents show three specific roles for him:

  • Fauci caused our government to bankroll reckless and illegal gain-of-function experiments on bat coronaviruses in Wuhan while chasing the trillion-dollar dream of “universal vaccines,” an item worth billions to Big Pharma; 
  • Fauci worked the phones behind the scenes to steer IC analysts toward a convenient (and false) natural-origin conclusion; 
  • Fauci then stood in front of cameras playing the part of America’s trusted pandemic czar and — per the release — fed the public a steady diet of lies, disinformation, and censorship.

Quite the résumé, wouldn’t you say? But wait, there’s more!

Keep reading

He ‘Lied’: Tulsi Gabbard Releases Evidence Fauci Allegedly Directed Funding for ‘Risky’ Coronavirus Research Linked to Big Pharma and Pursuit of ‘Universal Vaccines’

Director of National Intelligence (DNI) Tulsi Gabbard used her last day in office to release a trove of evidence that Dr. Anthony Fauci – former director of the National Institute of Allergy and Infectious Diseases (NIAID) – lied to Congress and directed U.S. funding for gain-of-function research linked to Big Pharma’s pursuit of “universal vaccines,” all while influencing and manipulating the intelligence community to cover up his role in the coronavirus pandemic. 

Gabbard, who is leaving her post to help her husband as he battles an “extremely rare” form of cancer, released a trove of documents on her last day in office showcasing what many have said for years: Fauci lied to cover up his own alleged wrongdoing.

The Trump administration is blowing the lid off the coverup completely, showcasing Fauci’s role in providing millions in U.S. taxpayer dollars to fund dangerous gain-of-function research at the Wuhan Institute of Virology – where that specific coronavirus is suspected to originate.

Gabbard said:

Today, on my final day as Director of National Intelligence, I’m releasing never before seen communications and documents that expose exactly how Fauci worked with politicized career leadership in the intelligence community to suppress the truth about his actions, the virus’s lab leak origins, and his role in directing U.S. funding for this dangerous research that caused immeasurable harm and countless lost lives.

Gabbard alleged that those documents clearly “expose Fauci’s direct role in influencing and manipulating IC assessments on COVID-19, and how Fauci lied to Congress in 2024 when, under oath, he denied knowledge of or participation in discussions with intelligence officials about viral research.”

Gabbard also revealed they have testimony from intelligence community whistleblowers “who reported retaliation for challenging the intelligence community’s manipulation of intelligence on the virus’s origins.”

Ultimately, Gabbard said Fauci was able to use his “close relationships” with the intelligence community to “shield him from scrutiny.” During that time, Fauci funded gain-of-function coronavirus research “linked to big pharma and their pursuit of universal vaccines worth trillions of dollars,” Gabbard explained.

She also said Fauci pressed the intelligence community to push the “natural” animal origin narrative of the virus to cover for himself, and he became “the nation’s pandemic pundit” where he was able to freely push his alleged lies and censorship of critics.

Gabbard said the documents show Fauci pushed a “fraudulent” paper and “blatantly lied to Congress during his 2024 testimony to the House Select Subcommittee on the coronavirus pandemic, denying that he ever spoke to any intelligence agency about COVID.”

“The correspondence I’m releasing today directly contradicts his sworn testimony,” she said, “and we received statements from multiple whistleblowers revealing that the intelligence analysts who dared to challenge Dr. Fauci’s COVID origin conclusions faced threats of retaliation, marginalization, and many suffered career setbacks.”

“The COVID pandemic caused tremendous hardship and pain for millions of our fellow Americans and countless people around the world. Now, after years of lies and censorship and cover-ups, the American people deserve transparency, truth, and accountability,” Gabbard continued.

“The tactics that were used to hide the truth are straight from the deep state playbook,” she said, declaring that it is now time for the American people to have the truth. “Politicized, self-serving leaders like Dr. Fauci covered up their own wrongdoing and abuses of power, manipulated intelligence, lied to Congress, and undermined a duly elected president by restricting his access to the vital facts he needed to keep the country safe.”

Keep reading

Despite Over 100 Deaths in Moderna’s mRNA Flu Trial – Committee Recommends that the FDA Move Forward with Approval

June 18, 2026: Moderna just announced that, “the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 9-0 that the benefits of mRNA-1010, Moderna’s investigational seasonal influenza vaccine, outweigh its risks for the prevention of influenza disease in adults 50 through 64 years of age and in adults 65 years of age and older.”

This is despite the fact that Moderna reported 102 deaths in the mRNA group and 97 deaths in the ‘enhanced vaccine’ group.

102 reported deaths out of 35,965 mRNA injected study participants equate to a 0.3% fatal adverse event (death) rate in less than a year of being injected.

Adults aged 50-64 have a 0.015% of dying from the flu vs. 0.3% from a flu injection = a 20-fold (1900%) increase).

Adults 65 and older have a 0.05% chance of dying from the flu vs 0.3% from a flu injection = 6-fold (500%) increase.

Keep reading

Lawmakers Consider Hiking Fees for Filling Prescriptions

Legislation that would potentially increase New York’s pharmacy costs by hundreds of millions of dollars annually is moving toward final passage in Albany’s end-of-session rush.

The bill would require the companies that process prescription drug claims on behalf of most health plans – known as pharmacy benefit managers or PBMs – to pay pharmacies minimum prices for drugs, including a dispensing fee of $10.18 for each prescription filled.

That represents a roughly 400 percent increase over current dispensing fees, which average about $2, which would add about $570 million per year to drug costs for health plans, employers and consumers, according to an estimate from the Pharmaceutical Care Management Association, which represents PBMs.

Sponsored by Assemblyman John McDonald of Albany County, a former pharmacy owner, and Sen. James Skoufis of Orange County, the so-called Patient Access to Pharmacy Act passed the Senate last week by a vote of 58-2.

In the Assembly, the bill moved through the Ways and Means and Rules committees on Thursday, setting it up for a possible vote by the full house before lawmakers adjourn for the summer, which is scheduled to happen Friday.

The Senate previously approved the legislation at the end of last year’s session, but it was never taken up by the Assembly.

The bill mirrors a regulatory proposal put forward by the Department of Financial Services in the fall of 2023 – but which the department dropped in the face of widespread opposition from insurers, employers and labor unions.

In response to that opposition, the bill’s sponsors amended the bill to exempt the “collectively bargained” health plans covering union members. It also does not apply to Medicare or the “self-insured” health plans offered by most large employers, which are exempt from state regulation by federal law.

As a result, the bill primarily targets the health plans purchased from insurance companies by small and medium-sized employers – where it will add to premium costs that are already among the highest in the U.S.

Critics have also argued that the mandate would apply to the state-run Essential Plan and Child Health Plus, although Skoufis said that had not been the intent.

The bill would not affect the state’s Medicaid health plan for the low-income and disabled, because it already pays a dispensing fee of $10.18 – which is the basis for the fee in the McDonald-Skoufis legislation.

Keep reading

Drug Testing Industry And Pharmaceutical Company Ask Court To Pause Trump’s Marijuana Rescheduling Move

An industry association that represents drug testing companies and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to block the Trump administration from moving forward with federal marijuana rescheduling while ongoing litigation challenging the reform is considered—claiming that cannabis is a “dangerous drug that destroys lives.”

The National Drug and Alcohol Screening Association (NDASA), along with MMJ International Holdings and its subsidiaries, argue in the new filing on Tuesday that the cannabis rescheduling move is “a brazen agency overreach in which the Acting Attorney General ignored restrictions on his authority set by Congress—and a binding decision of this Court—to carry out one of the most sweeping reductions in restrictions on a dangerous narcotic in the history of the Controlled Substances Act (CSA).”

“Nearly fifty years ago, this Court held that the Attorney General lacks authority to unilaterally decide how marijuana ought to be restricted—that is, which Schedule it should be placed under—pursuant to the CSA. The Court explained that Congress constrained the Attorney General’s authority by requiring him both to secure recommendations from the Secretary of Health and Human Services (HHS) and to make detailed findings through a formal rulemaking on the record. While the CSA contains a limited bypass of those procedures to allow the Attorney General to ensure that the U.S. complies with certain treaties…this Court made clear that the bypass cannot be invoked when the Attorney General is simply deciding to move a drug between two Schedules under the CSA, either of which would comply with treaty obligations.”

“The Department of Justice complied with this Court’s construction of the CSA for over four decades—until now,” the joint motion for a stay pending review that was filed before the U.S. Court of Appeals for the District of Columbia Circuit argues.

While HHS had issued a recommendation to reschedule marijuana during the Biden administration, the recent move by the Trump Department of Justice canceled ongoing proceedings related to that proposal and issued a new final rule.

Keep reading

Exposing The Great Acid Reflux Scam

•Many commonly prescribed medications are given to patients despite the risks often outweighing the benefits.

•Acid-suppressing drugs are among the worst offenders, with their overuse fueled by a lack of understanding about the crucial role of stomach acid throughout the body or that acid reflux is due to too little stomach acid (as the stomach acid of digestion gives the stomach’s opening a signal to seal and not let any more food in).

•Deficient stomach acid causes many chronic health problems (e.g., macular degeneration, a myriad of autoimmune disorders such as asthma, and less overt forms of reflux that cause many common diseases of the ears, nose, and throat such as allergies, coughs, and sinusitis).

•Acid blocking medications cause a variety of severe side effects, including a 19% increased risk of death and a comparable increase in cardiac events, kidney or liver disease, numerous infections, and bone damage.

•Thankfully, many safe natural treatments can effectively address acid reflux and many of the complications of a chronic stomach acid deficiency.

In the U.S., 66% of adults are estimated to have at least one prescription, and the average person has nine filled annually. As an awake physician, one of the most depressing aspects of my work is seeing patients, especially the elderly, weighed down by numerous prescriptions that frequently do more harm than good.

For example, as I showed here, statins provide a negligible benefit (e.g., at best, taking them for five years extends one’s lifespan by 3-4 days) but create significant side effects such as severe muscle pain and cognitive impairment for 20% of users.

This tragic situation is best demonstrated by a 2007 study which showed that simply discontinuing the least necessary prescriptions resulted in a 23% reduction in the death rate and an 18.2% decrease in hospital referrals. Sadly, since the trend in medicine is always to have people on more drugs, data like this has had no effect on the practice of the overprescription of medications.

Keep reading

The Crisis Creators – Why Behavioral Health Makes Everything Worse

If anyone hasn’t figured out yet where too much of America’s health problems begin, look no further than the behavioral health industry. It’s time to take a serious look.

While the federal government is in an all-out offensive to uncover fraud in State Medicaid programs, the real fraud lies in the psychiatric diagnosing that has gone unchecked for a hundred years and brought the nation to a mental health crisis.

Just this month alone, the Health and Human Services Secretary, Robert F. Kennedy, Jr., has begun a national campaign to reduce the use of psychiatric drugs by publishing “deprescribing” guidance and training for doctors for any number of the tens of millions of Americans who are taking Selective Serotonin Reuptake Inhibitors (SSRIs) commonly referred to as antidepressants.

Here’s the truth. The modern mental health model of diagnosis and drug treatment is an enormous failure. People have been harmed for years using antidepressants, and go figure, the medical community admits it’s hard to get off prescription mind-altering drugs. The goal of the HHS Secretary is to finally make drugs one of many options for “treatment” of mental illnesses. But is that enough? Is that really the answer to over-prescribing?

It’s a fact. Americans can’t get the drugs without a mental disorder diagnosis, and the diagnoses are not based on science. In other words, there isn’t anything broken in anyone’s brain that can be medically measured…no X-ray, CAT Scan, blood or urine test can identify any of the alleged mental disorders. And, the fact is, if an abnormality was discovered in the brain, most likely a neurologist would be utilized…not a psychiatrist. Neurologists study brain disease, and psychiatrists study behavior. A very big difference that has been ignored in the modern mental health model.

Keep reading

FDA Ousts Another Top Official: Who’s Behind the Shakeup — and Why?

Tracy Beth Høeg, M.D., Ph.D., an epidemiologist and sports physician who supported studying — and reducing — the recommended childhood vaccination schedule, was fired by the U.S. Food and Drug Administration (FDA). Høeg was acting director of the FDA’s Center for Drug Evaluation and Research (CDER).

In a post on X last Friday, Høeg wrote that she “learned so much” and is leaving the FDA “with no regrets.”

And in an interview with MD Reports published shortly after her firing, Høeg said she first learned about the agency’s plans to fire her earlier in the week, through media reports.

On May 15, two unnamed FDA officials offered her the choice to resign or be fired. When she refused to resign, she was fired on the spot.

“I said I didn’t want to resign,” Høeg told MD Reports. “I said I’m not signing a letter of resignation if it’s not my choice.”

During her time at the FDA, Høeg was involved in several research initiatives broadly tied to the Make America Healthy Again (MAHA) agenda. According to The New York Times, this included work on an “intense investigation” last year that linked the COVID-19 vaccines to “at least” 10 child deaths.

Høeg also authored a report recommending that the number of diseases covered by the recommended childhood vaccination schedule be reduced from 17 to 11.

In January, U.S. Health Secretary Robert F. Kennedy Jr. implemented these recommendations. However, in March, a federal court issued a stay pausing adoption of the new schedule.

According to The Associated Press, Høeg was most recently involved in the FDA’s review of a petition to add new warnings to antidepressants about risks to pregnant women, “including fetal abnormalities that could lead to autism and other disorders.”

Keep reading

Trump Praises Liberal Billionaire Mark Cuban at White House TrumpRX Event, Says Kamala Harris Endorsement Was “a Big Mistake”

Mark Cuban, the liberal former Dallas Mavericks owner and Shark Tank co-host, made an appearance alongside President Trump at the White House on Monday to announce an expansion of the President’s TrumpRX website. 

Cuban’s online pharmacy, Cost Plus Drugs, along with Amazon Pharmacy and GoodRx, are set to list over 600 generic drugs on TrumpRX at lower costs for consumers. Cuban said 559 of the drugs come from his company.

“I’ve been the biggest proponent of TrumpRX.com,” Cuban said in brief remarks at the event. “Republicans want cheaper drugs. Independents want cheaper drugs. Democrats want cheaper drugs. And together, I think we’re going to do something special.”

However, Cuban has never supported Trump, frequently attacking him and supporting Kamala Harris in 2024.

One America News Network’s Daniel Baldwin asked the President about Cuban’s history as a Never Trumper, and Trump squashed the beef.

“he’s got a good company, and he’s going to do a lot of business with this,” Trump said, describing Cuban as “very gracious.” He continued, “I think I have a lot of respect for Mark, frankly, and I always have.”

Keep reading

Ozempic Face? Try Ozempic Pancreatitis: Inside the GLP-1 Profit Model

If you thought “Ozempic face” was bad, wait till you hear what it’s doing inside the body.

A massive study involving 16 million people found GLP-1 users had a 9.09 times greater risk of pancreatitis, 4.22 times greater risk of bowel obstruction, and a 3.67 times greater risk of stomach paralysis.

And if you’ve ever had pancreatitis, it is “quite a painful experience.”

What you’re hearing on the news about Ozempic is still too little, too late.

Here’s the story you’re not getting about Ozempic, the business model behind it, and why a growing number of researchers believe another pharmaceutical disaster is already unfolding in real time.

In early 2023, JP Morgan hosted its annual healthcare conference—a private, invitation-only event it describes as “the industry’s biggest gathering.”

The keynote speakers included the chairman of JPMorgan Chase, the CEO of Eli Lilly, and several managing directors of major healthcare venture capital firms.

The fourth keynote was Dr. Robert Califf.

His day job at the time: Commissioner of Food and Drugs for the United States Food and Drug Administration.

Hmm…

This wasn’t a public health symposium. It wasn’t an academic conference.

It was specifically designed for large investors, and its explicit purpose was to set the pharmaceutical industry’s financial priorities for the year ahead.

A pharmaceutical safety advocate named Kim Witczak obtained what she could from the conference’s public-facing website.

But what was being said behind closed doors?

Keep reading